Physician profile
Christopher B Caldwell
NPI 1982694733
$980.47
in general payments reported to CMS, 2019-2025
12 companies · $69.71 in 2025
The $69.71 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $308 · 2020: $13.55 · 2021: $105 · 2022: $241 · 2023: $40.77 · 2024: $202 · 2025: $69.71.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $312.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $312.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $299.25 | 2019-2022 | |
| Davol INC. | $160.01 | 2024 | Phasix Mesh |
| Medtronic, INC. | $117.39 | 2022 | |
| Ethicon US, LLC | $91.58 | 2019-2025 | Harmonic, Enseal, Echelon; Endopath |
| Pacira Pharmaceuticals Incorporated | $89.06 | 2021 | |
| Abbvie INC. | $88.57 | 2022 | |
| Myriad Genetic Laboratories, INC. | $41.64 | 2024-2025 | Myrisk |
| Organogenesis INC. | $22.16 | 2023 | Puraply |
| Aroa Biosurgery Incorporated | $20.76 | 2024 | |
| Nestle Healthcare Nutrition INC. | $18.92 | 2022 | |
| Kci USA, INC. | $18.61 | 2023 | Prevena, V.A.C. Dermatac, Activ.A.C. |
| Leica Microsystems INC. | $12.52 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Caldwell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.